These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23302155)

  • 1. Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study.
    Gérardin P; Fianu A; Michault A; Mussard C; Boussaïd K; Rollot O; Grivard P; Kassab S; Bouquillard E; Borgherini G; Gaüzère BA; Malvy D; Bréart G; Favier F
    Arthritis Res Ther; 2013 Jan; 15(1):R9. PubMed ID: 23302155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study.
    Gérardin P; Fianu A; Malvy D; Mussard C; Boussaïd K; Rollot O; Michault A; Gaüzere BA; Bréart G; Favier F
    BMC Med; 2011 Jan; 9():5. PubMed ID: 21235760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatism and chronic fatigue, the two facets of post-chikungunya disease: the TELECHIK cohort study on Reunion island.
    Duvignaud A; Fianu A; Bertolotti A; Jaubert J; Michault A; Poubeau P; Fred A; Méchain M; Gaüzère BA; Favier F; Malvy D; Gérardin P
    Epidemiol Infect; 2018 Apr; 146(5):633-641. PubMed ID: 29486812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chikungunya virus infection in Aruba: Diagnosis, clinical features and predictors of post-chikungunya chronic polyarthralgia.
    Huits R; De Kort J; Van Den Berg R; Chong L; Tsoumanis A; Eggermont K; Bartholomeeusen K; Ariën KK; Jacobs J; Van Esbroeck M; Bottieau E; Cnops L
    PLoS One; 2018; 13(4):e0196630. PubMed ID: 29709007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Persistence of Chikungunya Virus-Associated Manifestations and Anti-Chikungunya Virus Antibody in Southern Thailand: 5 Years After an Outbreak in 2008-2009.
    Ninla-Aesong P; Mitarnun W; Noipha K
    Viral Immunol; 2020 Mar; 33(2):86-93. PubMed ID: 31976828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice.
    Arévalo MT; Huang Y; Jones CA; Ross TM
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007316. PubMed ID: 31026260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
    Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
    Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors of post chikungunya rheumatic musculoskeletal disorders: a prospective follow-up study in French Guiana.
    Bonifay T; Lienne JF; Bagoée C; Santa F; Vesin G; Walter G; Nacher M; Vaserman N; Djossou F; Epelboin L
    Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2159-2164. PubMed ID: 30120648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-based sero-prevalence of chikungunya and yellow fever in the South Omo Valley of Southern Ethiopia.
    Endale A; Michlmayr D; Abegaz WE; Asebe G; Larrick JW; Medhin G; Legesse M
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008549. PubMed ID: 32881913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number variation of Chikungunya ECSA virus with disease symptoms among Indian patients.
    Dutta SK; Pal T; Saha B; Mandal S; Tripathi A
    J Med Virol; 2014 Aug; 86(8):1386-92. PubMed ID: 24132555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatic manifestations of Chikungunya virus infection: Prevalence, patterns, and enthesitis.
    Benjamanukul S; Osiri M; Chansaenroj J; Chirathaworn C; Poovorawan Y
    PLoS One; 2021; 16(4):e0249867. PubMed ID: 33886579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Perceived morbidity and community burden of chikungunya in La Reunion].
    Gérardin P; Fianu A; Malvy D; Mussard C; Boussaïd K; Rollot O; Michault A; Gaüzere BA; Bréart G; Favier F
    Med Trop (Mars); 2012 Mar; 72 Spec No():76-82. PubMed ID: 22693934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
    Yoon IK; Alera MT; Lago CB; Tac-An IA; Villa D; Fernandez S; Thaisomboonsuk B; Klungthong C; Levy JW; Velasco JM; Roque VG; Salje H; Macareo LR; Hermann LL; Nisalak A; Srikiatkhachorn A
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003764. PubMed ID: 25951202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of Chikungunya Virus in a Rural Community in Brazil.
    Cunha RV; Trinta KS; Montalbano CA; Sucupira MV; de Lima MM; Marques E; Romanholi IH; Croda J
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005319. PubMed ID: 28107342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial.
    Folegatti PM; Harrison K; Preciado-Llanes L; Lopez FR; Bittaye M; Kim YC; Flaxman A; Bellamy D; Makinson R; Sheridan J; Azar SR; Campos RK; Tilley M; Tran N; Jenkin D; Poulton I; Lawrie A; Roberts R; Berrie E; Rossi SL; Hill A; Ewer KJ; Reyes-Sandoval A
    Nat Commun; 2021 Jul; 12(1):4636. PubMed ID: 34330906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Household Cluster Investigations to Identify Factors Associated with Chikungunya Virus Infection and Frequency of Case Reporting in Puerto Rico.
    Bloch D; Roth NM; Caraballo EV; Muñoz-Jordan J; Hunsperger E; Rivera A; Pérez-Padilla J; Rivera Garcia B; Sharp TM
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005075. PubMed ID: 27764085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and clinical manifestations of chikungunya virus infection in rural areas of Chandrapur, Maharashtra, India.
    Kawle AP; Nayak AR; Bhullar SS; Borkar SR; Patankar SD; Daginawala HF; Singh LR; Kashyap RS
    J Vector Borne Dis; 2017; 54(1):35-43. PubMed ID: 28352044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes.
    Yaseen HM; Simon F; Deparis X; Marimoutou C
    BMC Musculoskelet Disord; 2014 Jul; 15():249. PubMed ID: 25059583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical manifestation and the influence of age and comorbidities on long-term chikungunya disease and health-related quality of life: a 60-month prospective cohort study in Curaçao.
    Doran C; Gerstenbluth I; Duits A; Lourents N; Halabi Y; Burgerhof J; Tami A; Bailey A
    BMC Infect Dis; 2022 Dec; 22(1):948. PubMed ID: 36526964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of chikungunya seropositivity in healthy Malaysian adults residing in outbreak-free locations: chikungunya seroprevalence results from the Malaysian Cohort.
    Azami NA; Salleh SA; Shah SA; Neoh HM; Othman Z; Zakaria SZ; Jamal R
    BMC Infect Dis; 2013 Feb; 13():67. PubMed ID: 23379541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.